November 9, 2021 Comments Off on New tentative approval for Radius Health drug abaloparatide Posted in: Tentative Approval Abaloparatide is the generic ingredient in one branded drug marketed by Radius Health Inc and is included in one NDA. There are four patents protecting this compound. This ingredient has…
The post New tentative approval for Radius Health drug abalopara…
November 9, 2021 Comments Off on New patent for Exelixis Inc drug CABOMETYX Posted in: Patent Added Annual Drug Patent Expirations for CABOMETYX Cabometyx is a drug marketed by Exelixis Inc and is included in one NDA. It is available from one supplier. There are nine patents…
The post New patent for Exelixis Inc drug CABOMETYX appeared first on DrugP…
